Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/03/85/bf/0385bf00-4f5f-1d37-7e70-cdfd5676802b/mza_1155440752639581066.jpeg/600x600bb.jpg
"Second Opinion" with Christina Farr, Ash Zenooz MD & Luba Greenwood JD
Christina Farr, Luba Greenwood, Ash Zenooz
39 episodes
4 months ago
If you’re obsessed with health-tech and life sciences, this is the podcast for you. Second Opinion doesn't hold back. Join Luba Greenwood, Christina Farr, and Ash Zenooz as they bring influential entrepreneurs, experts and investors into the ring for candid conversations at the frontlines of healthcare and digital health every week. Healthcare, health-tech and life sciences in particular, is hard to navigate even for the most seasoned professionals. Unpacking the latest technological, medical, and scientific advances, regulatory hurdles, global economic shifts, and industry and investment trends, requires a powerful combination of hosts like us. We aim to sift through the noise and help you navigate what’s really going on in healthcare and how to spot the next win. This season, we’re tackling meaty topics like biosecurity, the latest in telemedicine, why patient acquisition is so hard, and the pros and cons of VC versus private equity in funding startups in the healthtech space. Christina Farr is a former investigative journalist for CNBC — during her tenure as a reporter, she broke some big health-tech stories ranging from Amazon’s first moves into the sector to Apple’s secretive acquisitions. Now Christina is the author at Second Opinion, a newsletter with +20K subscribers. Joining Christina are co-hosts Luba Greenwood, JD — former CEO of Kojin Therapeutics and managing partner at Dana-Farber Cancer Institute — and Ash Zenooz, MD — former CEO of Commure and partner at Luxeda Holdings.  Second Opinion is is a part of the Turpentine podcast network. Learn more: turpentine.co
Show more...
Technology
Business,
Investing,
Health & Fitness
RSS
All content for "Second Opinion" with Christina Farr, Ash Zenooz MD & Luba Greenwood JD is the property of Christina Farr, Luba Greenwood, Ash Zenooz and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
If you’re obsessed with health-tech and life sciences, this is the podcast for you. Second Opinion doesn't hold back. Join Luba Greenwood, Christina Farr, and Ash Zenooz as they bring influential entrepreneurs, experts and investors into the ring for candid conversations at the frontlines of healthcare and digital health every week. Healthcare, health-tech and life sciences in particular, is hard to navigate even for the most seasoned professionals. Unpacking the latest technological, medical, and scientific advances, regulatory hurdles, global economic shifts, and industry and investment trends, requires a powerful combination of hosts like us. We aim to sift through the noise and help you navigate what’s really going on in healthcare and how to spot the next win. This season, we’re tackling meaty topics like biosecurity, the latest in telemedicine, why patient acquisition is so hard, and the pros and cons of VC versus private equity in funding startups in the healthtech space. Christina Farr is a former investigative journalist for CNBC — during her tenure as a reporter, she broke some big health-tech stories ranging from Amazon’s first moves into the sector to Apple’s secretive acquisitions. Now Christina is the author at Second Opinion, a newsletter with +20K subscribers. Joining Christina are co-hosts Luba Greenwood, JD — former CEO of Kojin Therapeutics and managing partner at Dana-Farber Cancer Institute — and Ash Zenooz, MD — former CEO of Commure and partner at Luxeda Holdings.  Second Opinion is is a part of the Turpentine podcast network. Learn more: turpentine.co
Show more...
Technology
Business,
Investing,
Health & Fitness
https://megaphone.imgix.net/podcasts/4b472566-dde5-11ef-9056-1f4d688f0194/image/61f73cf6b953b582834832748046866a.png?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress
Dr. Dean Ornish proved heart disease Is reversible. Now he's doing it with Alzheimer's
"Second Opinion" with Christina Farr, Ash Zenooz MD & Luba Greenwood JD
46 minutes
10 months ago
Dr. Dean Ornish proved heart disease Is reversible. Now he's doing it with Alzheimer's
Ash Zenooz and Luba Greenwood interview Dr. Dean Ornish, a cardiologist, researcher, and advocate for lifestyle medicine who notably treated Bill Clinton. They discuss his journey into preventative medicine, the development of the Ornish Diet, and his data showing reversal of chronic diseases and improving overall health and longevity. — 📰 Be notified early when Turpentine drops new publication: https://www.turpentine.co/exclusiveaccess   🙏 Help shape our show by taking our quick listener survey at https://bit.ly/TurpentinePulse    — SPONSOR:  👩‍⚕️ Hot flashes, insomnia, brain fog? You don't have to accept these as just another part of aging. Midi Health is the virtual care clinic for women navigating midlife hormonal transition, offering FDA-approved medications, supplements and lifestyle coaching - all covered by insurance. Visit https://www.joinmidi.com/ to book your virtual visit today. — LINKS:  Ornish Lifestyle Medicine: https://ornish.com/  Michael E. DeBakey, M.D.: https://www.bcm.edu/about-us/our-campus/debakey-museum/legacy-of-excellence Books by Dr. Ornish (mentioned): Love and Survival: https://www.amazon.com/Love-Survival-Scientific-Healing-Intimacy/dp/0060172134 Undo It: https://www.amazon.com/Undo-Lifestyle-Changes-Reverse-Diseases/dp/052547997X  The Spectrum: https://www.amazon.com/Spectrum-Scientifically-Proven-Program-Better/dp/0345496310  Eat More, Weigh Less: https://www.amazon.com/Eat-More-Weigh-Less-Abundantly/dp/006109627X    Subscribe to Second Opinion Newsletter: https://secondopinion.media/  — FOLLOW: https://www.linkedin.com/in/dean-ornish-m-d-1057167/  https://www.linkedin.com/company/preventive-medicine-research-institute/  https://www.linkedin.com/in/christinafarr/ https://www.linkedin.com/in/lubagreenwood/ https://www.linkedin.com/in/ashzenooz/ — HIGHLIGHTS FROM THE EPISODE: Dr. Ornish took a year off medical school to conduct a pilot study, finding that 8 out of 10 patients showed improved blood flow to their hearts through lifestyle changes alone. The landmark Lifestyle Heart Trial proved that arteries could become less clogged through lifestyle changes. The program crystallized into four key elements: whole foods plant-based diet, moderate exercise, stress management through meditation/yoga, and social support groups. It took 16 years of effort to get Medicare to cover the program, demonstrating that changing medical practice required changing reimbursement structures. The program achieved a remarkable 93% completion rate because participants felt better quickly, compared to only one-third of people staying on statins after a few months. Research with Nobel laureate Elizabeth Blackburn showed these lifestyle changes could lengthen telomeres, potentially reversing aging at a cellular level. Recent studies demonstrated the same program could stop or reverse early-stage Alzheimer's progression in 71% of participants within 20 weeks. Data from health insurers showed significant cost savings: 80% of cardiac patients avoided surgery, saving $30,000 per patient in the first year. Studies of over 20,000 participants revealed a nearly 50% reduction in depression scores through the program. President Clinton's adoption of the program helped demonstrate its effectiveness to a broader audience and influenced healthcare policy. The program's core philosophy emphasizes joy and immediate benefits over fear of future consequences, making the changes more sustainable. For disease reversal (versus prevention), patients need 80-100% adherence to the program's principles.
"Second Opinion" with Christina Farr, Ash Zenooz MD & Luba Greenwood JD
If you’re obsessed with health-tech and life sciences, this is the podcast for you. Second Opinion doesn't hold back. Join Luba Greenwood, Christina Farr, and Ash Zenooz as they bring influential entrepreneurs, experts and investors into the ring for candid conversations at the frontlines of healthcare and digital health every week. Healthcare, health-tech and life sciences in particular, is hard to navigate even for the most seasoned professionals. Unpacking the latest technological, medical, and scientific advances, regulatory hurdles, global economic shifts, and industry and investment trends, requires a powerful combination of hosts like us. We aim to sift through the noise and help you navigate what’s really going on in healthcare and how to spot the next win. This season, we’re tackling meaty topics like biosecurity, the latest in telemedicine, why patient acquisition is so hard, and the pros and cons of VC versus private equity in funding startups in the healthtech space. Christina Farr is a former investigative journalist for CNBC — during her tenure as a reporter, she broke some big health-tech stories ranging from Amazon’s first moves into the sector to Apple’s secretive acquisitions. Now Christina is the author at Second Opinion, a newsletter with +20K subscribers. Joining Christina are co-hosts Luba Greenwood, JD — former CEO of Kojin Therapeutics and managing partner at Dana-Farber Cancer Institute — and Ash Zenooz, MD — former CEO of Commure and partner at Luxeda Holdings.  Second Opinion is is a part of the Turpentine podcast network. Learn more: turpentine.co